iData Insights

Asahi Kasei Pharma Corp. - Product Pipeline Review – 2015 Is Released

Press Release   •   Feb 04, 2016 17:32 IST

This report provides comprehensive information on the current therapeutic developmental pipeline of Asahi Kasei Pharma Corp.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Asahi Kasei Pharma Corp.

including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Asahi Kasei Pharma Corp.s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Asahi Kasei Pharma Corp.s pipeline products Reasons to buy - Evaluate Asahi Kasei Pharma Corp.s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Asahi Kasei Pharma Corp. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Asahi Kasei Pharma Corp. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Asahi Kasei Pharma Corp. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Asahi Kasei Pharma Corp. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Asahi Kasei Pharma Corp. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC http://www.idatainsights.com/reports-landing-page.php?id=179130/asahi-kasei-pharma-corp-product-pipeline-review-2015

To Get Sample Copy of Report visit http://www.idatainsights.com/reports-landing-page.php?id=179130/asahi-kasei-pharma-corp-product-pipeline-review-2015

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Asahi Kasei Pharma Corp. Snapshot 5

Asahi Kasei Pharma Corp. Overview 5

Key Information 5

Key Facts 5

Asahi Kasei Pharma Corp. - Research and Development Overview 6

Key Therapeutic Areas 6

Asahi Kasei Pharma Corp. - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Pipeline Products - Partnered Products 11

Partnered Products/Combination Treatment Modalities 12

Asahi Kasei Pharma Corp. - Pipeline Products Glance 13

Asahi Kasei Pharma Corp. - Late Stage Pipeline Products 13

Pre-Registration Products/Combination Treatment Modalities 13

Phase III Products/Combination Treatment Modalities 14

Asahi Kasei Pharma Corp. - Clinical Stage Pipeline Products 15

Phase II Products/Combination Treatment Modalities 15

Asahi Kasei Pharma Corp. - Early Stage Pipeline Products 16

Preclinical Products/Combination Treatment Modalities 16

Discovery Products/Combination Treatment Modalities 17

Asahi Kasei Pharma Corp. - Drug Profiles 18

zoledronic acid 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

mizoribine 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

thrombomodulin alfa 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

AK-106 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

elcatonin 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

fasudil 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

pentosan polysulfate sodium 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

ATS-8535 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

Small Molecules to Antagonize EP1 Receptor for Overactive Bladder 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Small Molecule for Rheumatoid Arthritis and Autoimmune Diseases 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Small Molecules to Inhibit ADAMTS-5 for Osteoarthritis 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Asahi Kasei Pharma Corp. - Pipeline Analysis 32

Asahi Kasei Pharma Corp. - Pipeline Products by Target 32

Asahi Kasei Pharma Corp. - Pipeline Products by Route of Administration 34

Asahi Kasei Pharma Corp. - Pipeline Products by Molecule Type 35

Asahi Kasei Pharma Corp. - Pipeline Products by Mechanism of Action 36

Asahi Kasei Pharma Corp. - Recent Pipeline Updates 37

Asahi Kasei Pharma Corp. - Dormant Projects 38

Asahi Kasei Pharma Corp. - Discontinued Pipeline Products 39

Discontinued Pipeline Product Profiles 39

teriparatide acetate transdermal patch 39

Asahi Kasei Pharma Corp. - Locations And Subsidiaries 40

Head Office 40

Appendix 41

Methodology 41

Coverage 41

Secondary Research 41

Primary Research 41

Expert Panel Validation 41

Contact Us 41

Disclaimer 42" width="80" height="40" />Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Asahi Kasei Pharma Corp. Snapshot 5

Asahi Kasei Pharma Corp. Overview 5

Key Information 5

Key Facts 5

Asahi Kasei Pharma Corp. - Research and Development Overview 6

Key Therapeutic Areas 6

Asahi Kasei Pharma Corp. - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Pipeline Products - Partnered Products 11

Partnered Products/Combination Treatment Modalities 12

Asahi Kasei Pharma Corp. - Pipeline Products Glance 13

Asahi Kasei Pharma Corp. - Late Stage Pipeline Products 13

Pre-Registration Products/Combination Treatment Modalities 13

Phase III Products/Combination Treatment Modalities 14

Asahi Kasei Pharma Corp. - Clinical Stage Pipeline Products 15

Phase II Products/Combination Treatment Modalities 15

Asahi Kasei Pharma Corp. - Early Stage Pipeline Products 16

Preclinical Products/Combination Treatment Modalities 16

Discovery Products/Combination Treatment Modalities 17

Asahi Kasei Pharma Corp. - Drug Profiles 18

zoledronic acid 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

mizoribine 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

thrombomodulin alfa 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

AK-106 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

elcatonin 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

fasudil 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

pentosan polysulfate sodium 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

ATS-8535 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

Small Molecules to Antagonize EP1 Receptor for Overactive Bladder 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Small Molecule for Rheumatoid Arthritis and Autoimmune Diseases 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Small Molecules to Inhibit ADAMTS-5 for Osteoarthritis 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Asahi Kasei Pharma Corp. - Pipeline Analysis 32

Asahi Kasei Pharma Corp. - Pipeline Products by Target 32

Asahi Kasei Pharma Corp. - Pipeline Products by Route of Administration 34

Asahi Kasei Pharma Corp. - Pipeline Products by Molecule Type 35

Asahi Kasei Pharma Corp. - Pipeline Products by Mechanism of Action 36

Asahi Kasei Pharma Corp. - Recent Pipeline Updates 37

Asahi Kasei Pharma Corp. - Dormant Projects 38

Asahi Kasei Pharma Corp. - Discontinued Pipeline Products 39

Discontinued Pipeline Product Profiles 39

teriparatide acetate transdermal patch 39

Asahi Kasei Pharma Corp. - Locations And Subsidiaries 40

Head Office 40

Appendix 41

Methodology 41

Coverage 41

Secondary Research 41

Primary Research 41

Expert Panel Validation 41

Contact Us 41

Disclaimer 42

Read More http://www.idatainsights.com/reports-landing-page.php?id=179130/asahi-kasei-pharma-corp-product-pipeline-review-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

ContactUs:
iData Insights

Tel: 1-866-237-2965

Web: http://www.idatainsights.com
Email: info@idatainsights.com

AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future project.